Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 12, Status: Authorised

Report - Highlights of the 15th Industry Standing Group (ISG) meeting

One substance - one assessment (OSOA): EU collaboration on chemicals-related data

Questions and answers regarding co-processed excipients used in solid oral dosage forms

Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Dexdor, dexmedetomidine, Date of authorisation: 15/09/2011, Revision: 18, Status: Authorised

Quality of medicines questions and answers: Part 1

Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 21, Status: Authorised